Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study

BACKGROUND: Chronic migraine (CM) is associated with substantial economic burden. Real-world data suggests that onabotulinumtoxinA treatment for CM reduces healthcare resource utilisation (HRU) and related costs. METHODS: REPOSE was a 2-year prospective, multicentre, non-interventional, observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kollewe, Katja, Gaul, Charly, Gendolla, Astrid, Sommer, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173963/
https://www.ncbi.nlm.nih.gov/pubmed/34078259
http://dx.doi.org/10.1186/s10194-021-01260-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173963/
https://www.ncbi.nlm.nih.gov/pubmed/34078259
http://dx.doi.org/10.1186/s10194-021-01260-4

Ejemplares similares